| Adherence to antiretroviral therapy among Iranian HIV/AIDS patients H Khalili, R Rohani, S Seyedalinaghi, M Hajiabdolbaghi, ... Current clinical pharmacology 7 (2), 111-115, 2012 | 41 | 2012 |
| Optimizing aminoglycoside dosing regimens for critically ill pediatric patients with augmented renal clearance: a convergence of parametric and nonparametric population approaches SN Avedissian, R Rohani, J Bradley, J Le, NJ Rhodes Antimicrobial Agents and Chemotherapy 65 (4), 10.1128/aac. 02629-20, 2021 | 6 | 2021 |
| Machine learning to stratify methicillin-resistant Staphylococcus aureus risk among hospitalized patients with community-acquired pneumonia NJ Rhodes, R Rohani, PR Yarnold, AE Pawlowski, M Malczynski, C Qi, ... Antimicrobial agents and chemotherapy 67 (1), e01023-22, 2023 | 5 | 2023 |
| Flucloxacillin worsens while imipenem–cilastatin protects against vancomycin‐induced kidney injury in a translational rat model GM Pais, S Marianski, K Valdez, RP Melicor, J Liu, R Rohani, J Chang, ... British Journal of Pharmacology 181 (5), 670-680, 2024 | 2 | 2024 |
| Defining the importance of age-related changes in drug clearance to optimizing aminoglycoside dosing regimens for adult patients with cystic fibrosis R Rohani, B Hoff, M Jain, A Philbrick, S Salama, JF Cullina, NJ Rhodes European Journal of Drug Metabolism and Pharmacokinetics, 1-11, 2022 | 2 | 2022 |
| 2560. Individual Meropenem Epithelial Lining Fluid and Plasma PK/PD Target Attainment in Patients with Pneumonia R Rohani, PR Yarnold, MH Scheetz, MN Neely, M Kang, HK Donnelly, ... Open Forum Infectious Diseases 10 (Suppl 2), 2023 | 1 | 2023 |
| Individual target pharmacokinetic/pharmacodynamic attainment rates among meropenem-treated patients admitted to the ICU with hospital-acquired pneumonia R Rohani, MH Scheetz, HK Donnelly, A Donayre, M Kang, E Diaz, ... Journal of Antimicrobial Chemotherapy 77 (11), 2956-2959, 2022 | 1 | 2022 |
| Expanding expedited partner therapy and HIV prophylaxis in the emergency department KJ Mercer, MB Brizzi, DN Burhoe, JM Senn, R Rohani, DN Nowicki, ... American Journal of Health-System Pharmacy 81 (8), 279-290, 2024 | | 2024 |
| Individual meropenem epithelial lining fluid and plasma PK/PD target attainment R Rohani, PR Yarnold, MH Scheetz, MN Neely, M Kang, HK Donnelly, ... Antimicrobial agents and chemotherapy 67 (12), e00727-23, 2023 | | 2023 |
| Pharmacological and Behavioral Interventions to Mitigate Premature Aging in Patients with HIV R Rohani, J Malakismail, E Njoku Current HIV/AIDS Reports 20 (6), 394-404, 2023 | | 2023 |
| Determination of Meropenem Stability in Simulated Bronchoalveolar Lavage Fluid (BALF) Samples R Rohani, MH Scheetz, RG Wunderink, A Misharin, K Dedicatoria, ... 2021 ACCP VIRTUAL Annual Meeting, 2021 | | 2021 |
Nathaniel J. RhodesMidwestern University在 midwestern.edu 的电子邮件经过验证
